The preliminary therapeutic evidence, plus the probable pharmacological benefits of 5‐MeO‐DMT vs . other classical psychedelics, has confirmed intriguing to scientists and pharmaceutical firms alike, fueling a escalating number of clinical trials which happen to be currently in many phases of enhancement (Table one). At the moment, two medical